Rofecoxib

Rofecoxib

SCHEMBL28953295

CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1.Cl

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS2

The experimentally established mechanism targets of Rofecoxib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PTGS2 known ✓ P35354 13/20 0.97
PTGS1 P23219 9/20 0.97
ABCB11 O95342 1/20 0.97
ALDH1A1 P00352 1/20 0.97
MT-CO2 P00403 1/20 0.97
HTR1A P08908 1/20 0.97
ADORA3 P0DMS8 1/20 0.97
MC4R P32245 1/20 0.97
KMT2A Q03164 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rofecoxib SCHEMBL4434618 0.98 PTGS2 (1.00) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
SCHEMBL5858026 0.98 PTGS2 (1.00) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL3050 0.98 PTGS2 (1.00) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL14163950 0.98 PTGS2 (1.00) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL7860859 0.97 PTGS2 (0.97) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL6598209 0.97 PTGS2 (0.97) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL6598222 0.92 PTGS2 (0.86) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL5120688 0.90 PTGS2 (0.83) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
Rofecoxib SCHEMBL14163949 0.88 PTGS2 (0.81) PTGS2PTGS1ABCB11ALDH1A1MT-CO2
SCHEMBL13524329 0.88 PTGS2 (1.00) PTGS2PTGS1ABCB11ALDH1A1MT-CO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929201-A Co-amorphous form of beta-lactoglobulin and a drug 泽里翁制药公司 2022-08-19 CN disclosed